Alkem Lab Break previous High With good Volume.
アップデート済
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
Revenue from Operation grew by11.7% YoY during thequarter, with EBITDA margin of 21.7% and Net Profit margin of 18.0%.
Highest Quaterly revinue of 3440 Crore, And highest net profit of 615 crore in sept quater.
Revenue from Operation grew by11.7% YoY during thequarter, with EBITDA margin of 21.7% and Net Profit margin of 18.0%.
Highest Quaterly revinue of 3440 Crore, And highest net profit of 615 crore in sept quater.
トレード終了: 利益確定目標に到達
関連の投稿
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。